A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE
- Radiotherapy is the primary therapeutic strategy for nasopharyngeal carcinoma.
- Radiotherapy may cause adverse effect such as xerostomia and mucositis.
- Amifostine has the ability of protecting the normal tissue but also has some side
effects.
PURPOSE
- This phase II trial is to study the protecting effect and safety of different Amifostine
regimens in patients with nasopharyngeal carcinoma.